General Motors Co
Change company Symbol lookup
Select an option...
GM General Motors Co
NDAQ Nasdaq Inc
DYYXF DB Commodity Double Long ETN
KIQ Kelso Technologies Inc
MMM 3M Co
CBOE Cboe Global Markets Inc
PFE Pfizer Inc
DOW Dow Inc
CZZ Cosan Ltd
MO Altria Group Inc
Go

Consumer Discretionary : Automobiles | Large Cap Blend
Company profile

General Motors Co designs, builds and sells trucks, crossovers, cars and automobile parts worldwide. The Company also provides automotive financing services through General Motors Financial Company, Inc. (GM Financial). GM North America (GMNA) and GM International (GMI) are its automotive segments. GMNA and GMI are meeting the demands of customers with vehicles developed, manufactured and/or marketed under the Buick, Cadillac, Chevrolet and GMC and Holden brands. Its brands offer luxury cars, crossovers, sport utility vehicles (SUVs) and sedans. The Company’s Car-and Ride-Sharing Maven is a shared vehicle marketplace. Through its subsidiary, OnStar, LLC (OnStar), it provides connected safety, security and mobility solutions for retail and fleet customers. GM Cruise is its global segment engaged in the development and commercialization of autonomous vehicle technology.

Price
Delayed
$25.72
Day's Change
0.86 (3.46%)
Bid
--
Ask
--
B/A Size
--
Day's High
25.85
Day's Low
24.67
Volume
(Heavy Day)

Today's volume of 6,171,169 shares is on pace to be much greater than GM's 10-day average volume of 13,893,816 shares.

6,171,169

Is Gilead Sciences, Inc. (GILD) Stock Outpacing Its Medical Peers This Year?

10:30 am ET May 6, 2020 (Zacks) Print

Investors focused on the Medical space have likely heard of Gilead Sciences, Inc.(GILD), but is the stock performing well in comparison to the rest of its sector peers? Let's take a closer look at the stock's year-to-date performance to find out.

Gilead Sciences, Inc.is one of 892 individual stocks in the Medical sector. Collectively, these companies sit at #1 in the Zacks Sector Rank. The Zacks Sector Rank considers 16 different sector groups. The average Zacks Rank of the individual stocks within the groups is measured, and the sectors are listed from best to worst.

The Zacks Rank is a successful stock-picking model that emphasizes earnings estimates and estimate revisions. The system highlights a number of different stocks that could be poised to outperform the broader market over the next one to three months. GILD is currently sporting a Zacks Rank of #2 (Buy).

Within the past quarter, the Zacks Consensus Estimate for GILD's full-year earnings has moved 0.31% higher. This is a sign of improving analyst sentiment and a positive earnings outlook trend.

Based on the most recent data, GILD has returned 21.79% so far this year. Meanwhile, stocks in the Medical group have lost about 3.01% on average. This shows that Gilead Sciences, Inc.is outperforming its peers so far this year.

To break things down more, GILD belongs to the Medical - Biomedical and Genetics industry, a group that includes 382 individual companies and currently sits at #16 in the Zacks Industry Rank. Stocks in this group have gained about 3.89% so far this year, so GILD is performing better this group in terms of year-to-date returns.

Investors with an interest in Medical stocks should continue to track GILD. The stock will be looking to continue its solid performance.


Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
 
Gilead Sciences Inc (GILD): Free Stock Analysis Report
 
To read this article on Zacks.com click here.

Earnings Calendar and Events Data provided by |Terms of Use| © 2020 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2020. All rights reserved.